2m 2m 2m 2m 2m 2m 2m
Exelixis (EXEL)
NASDAQ
$65.03+$0.45 (+0.69%)
Price as of Oct 22, 2026 7:52 PM EDT- $16.0BMarket Cap
- 78.99%1-Year Change
- BiotechnologyIndustry
Exelixis (EXEL)
$65.03+$0.45 (+0.69%)
EXEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $64.58 | ||
Change | +$0.19 (+0.30%) | ||
Open | $64.12 | ||
High | $64.78 | ||
Low | $64.11 | ||
Previous Close | $64.39 | ||
Volume | 1,494,337 | ||
30-Day Average Volume | 2,220,593 | ||
1-Week Change | 5.89% | ||
1-Month Change | 12.86% | ||
1-Year Change | 78.99% | ||
3-Year Change | 205.92% | ||
5-Year Change | 202.77% | ||
Fundamentals | |||
Shares Outstanding | 247.8M | ||
Total Assets | $2.5B | ||
Market Cap | $16.0B | ||
Enterprise Value | $15.7B | ||
Period: QTR TTM FY | |||
Revenue | $573.0M | ||
Net Income | $212.1M | ||
Free Cash Flow | $300.9M | ||
EBIT | $262.7M | ||
EBITDA | $269.7M | ||
Net Working Capital | $888.9M | ||
EPS | $0.82 | ||
Enterprise Value/EBITDA | 58 | ||
Enterprise Value/Revenue | 27 | ||
P/B | 9 | ||
P/E | 79 | ||
PEG | 21 | ||
Price/Free Cash Flow | 53 | ||
Price/Operating Cash Flow | 52 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue